Terms ending in 2026
Every in-force patent on Gilead Sciences, Inc.'s record whose computed term ends in 2026, whoever holds it now. Soonest term end first, then patent number.
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 7,642,339 | Antiviral Compounds In force · High confidence | Gilead Sciences, Inc. | In force | High confidence | |
| US 9,579,332 | Phosphonate Analogs of HIV Inhibitor Compounds In force · High confidence | Gilead Sciences, Inc. | In force | High confidence | |
| US 7,600,568 | Safety Vent Valve In force · High confidence | Gilead Sciences, Inc. | In force | High confidence | |
| US 7,871,991 | Phosphonate Analogs of HIV Inhibitor Compounds In force · High confidence | Gilead Sciences, Inc. | In force | High confidence |
4 of 4 patents shown. Soonest term end first, then patent number.
Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.